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quality in action

Evaluation of a Multidisciplinary Team Approach
for Generating Survivorship Care Plan Treatment
Summaries in Patients With Breast Cancer
Tommy Ivanics, MD1; Erica Proctor, MD1; Yalei Chen, PhD1; Haythem Ali, MD1; Dawn Severson, MD1; Hassan Nasser, MD1;
Sonja Colbert, RN1; Laura Susick, PhD1; Eleanor Walker, MD1; Lindsay Petersen, MD1; Jessica Bensenhaver, MD1; Randa Loutﬁ, MD1;
S. David Nathanson, MD1; and Lisa A. Newman, MD1,2

abstract

INTRODUCTION The optimal structure for survivorship care plan (SCP) programs and methodology for generating
treatment summaries (TSs) has not yet been deﬁned, but the Commission on Cancer and the National Accreditation Program for Breast Centers both mandate that participating oncology programs implement SCP-TS
processes for patients that have completed treatment.
METHODS We used the Institute for Healthcare Improvement’s Plan-Do-Study-Act model for conducting a quality
improvement project evaluating two different SCP-TS programs implemented at the Henry Ford Health System/
Henry Ford Cancer Institute’s Breast Oncology Program in Detroit, Michigan. System I involved TSs drafted by
nonspecialist breast clinic staff; System II involved TSs vetted through a multidisciplinary breast specialist
conference approach. Accuracy of basic documentation entries related to dates and components of treatment
were compared for the two approaches.

RESULTS Seventy-one System I and 93 System II documents were reviewed. Documentation was accurate in at
least 90% of documents for both systems regarding delivery of chemotherapy and/or endocrine therapy and for
documenting the identity of the various members of the cancer treatment team. Both systems had notable
inaccuracies in documenting type of surgery performed, but System II had fewer inaccuracies than System I
(33.78% v 51.67%, respectively; P = .05). System II, compared with System I, had fewer inaccuracies in
documenting date of diagnosis (9.68% v 25.35%, respectively; P = .01) and had less missing information for
dose of radiation delivered (9.33% v 33.9%, respectively; P , .01).
CONCLUSION A multidisciplinary team approach to drafting and reviewing SCP-TS documents improved content
accuracy for our program, but ongoing education regarding documentation of various surgical procedures is
warranted.
J Oncol Pract 15:e467-e474. © 2019 by American Society of Clinical Oncology
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The Institute of Medicine issued recommendations in
2006 that survivors of cancer receive a treatment
summary (TS) and survivorship care plan (SCP) as a
strategy to improve coordination of health care and to
optimize understanding and management of longterm sequelae of oncologic therapies.1 The Commission on Cancer (CoC) subsequently issued a mandate
and time line for all CoC-approved programs to enact
an SCP process that included delivery of TS to patients
who have completed their cancer treatment.2 The
National Accreditation Program for Breast Centers has
adopted a comparable set of SCP standards.3 Although the basic components of these SCP-TS documents are described, the methodology for generating
and delivering these documents was left to the discretion of individual cancer programs. Wide variation
exists in integration of physicians, midlevel providers,

and the electronic medical record (EMR) into SCP-TS
clinical processes, and little is known about the accuracy of the resulting documents.
METHODS
The Henry Ford Health System/Henry Ford Cancer
Institute serves the diverse metropolitan Detroit patient
population. The Henry Ford Health System/Henry Ford
Cancer Institute is CoC approved, and its multidisciplinary breast program is accredited by the National
Accreditation Program for Breast Centers. Our Breast
Program Leadership Committee (BPLC) convenes
monthly and includes representatives from surgery,
medical oncology, radiation, pathology, radiology,
oncology nursing/nurse navigators, and physical
therapy/rehabilitation medicine. The agenda for these
meetings routinely accommodates presentations of
new initiatives and quality improvement efforts.
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In March 2015, we initiated plans to comply with the CoC
mandate that SCP-TS documents be provided to 25% to
75% of eligible patients in a 2016 to 2018 phased-in
process.2 For breast cancer, eligible patients were initially deﬁned as patients with invasive, nonmetastatic disease, and the SCP-TS document had to be drafted and
shared with the patient within 1 year of completing treatment. The BPLC launched this effort by educating our
multidisciplinary breast program clinicians regarding the
CoC mandate and the components of an acceptable SCPTS document. This process included conference calls,
e-mails, Web-based teleconferences, and meetings with
American Cancer Society and CoC representatives. Designated members of the BPLC (H.A. and D.S.) developed
an EMR-accessible and CoC-compliant template for the
SCP-TS document.

A series of monthly multidisciplinary committee (MDC) SCP
conferences was planned (immediately after the BPLC
meetings), with attendees including physicians and midlevel providers. Other participants include representatives
from the primary care provider staff, rehabilitation medicine, cardiac oncology, and psycho-oncology. A roster of
patients who are within 1 to 3 months of their due date to
receive their SCP-TS documents is drafted a couple of
weeks in advance of each SCP conference, along with
assignments of the breast program specialist responsible
for drafting each document. These members of the specialty teams are then responsible for generating a preliminary SCP-TS document based on review of the EMR;
they present a summary of the patient and TS content for
the SCP conference.

During the initial phase of our SCP-TS program (System I),
individual members of each patient’s treatment team were
responsible for recognizing that the patient was due to
receive and discuss her SCP-TS. System I survivorship
documents were generated by either the breast oncology
staff that happened to be seeing the patient during the
relevant follow-up time line or one of the nurses designated
by the overall cancer program as being responsible for
drafting SCP-TS documents for patients with cancer seen
across various disease sites.

The ﬁrst monthly MDC-SCP conference convened October
2016. In June 2018, the SCP nurse (S.C.) generated a list of
System I and System II SCP-TS documents for comparative
review. Breast Oncology Program director (L.N.) drafted a
code sheet for standardized assessment of SCP-TS accuracies regarding names of treatment team, date of diagnosis, disease stage, tumor phenotype, and treatment
delivered.

By the second half of 2016, concerns were raised during
BPLC meetings regarding inadequate monitoring of SCP-TS
document accuracy. We decided to initiate a quality improvement project, and we hypothesized that a multidisciplinary, team-based approach to drafting and reviewing
SCP-TS documents (System II) would improve content
accuracy. We followed the Plan-Do-Study-Act (PDSA) approach as outlined by the Institute for Healthcare Improvement4 (Fig 1).

Impartial non-BPLC physicians (T.I. and H.N.) were tasked
with completing code sheets to verify accuracy of key elements in SCP-TS documents. An epidemiologist (L.S.) was
tasked with generating the database, and a statistician
(Y.C.) was tasked with analyzing the data. System II was
also evaluated in real time during ongoing BPLC open
discussions.

Step 1: Plan
We developed a new system (System II) that aligned our
SCP-TS program with the existing multidisciplinary tumor
board program for evaluating new patients. In addition to
mapping out appropriate treatment options, we began
assigning anticipated SCP-TS needs. Patients requiring
chemotherapy are assigned to have their SCP-TS drafted by
a member of the medical oncology team; patients requiring
surgery and no chemotherapy or radiation therapy are
assigned to a member of the surgical team; and patients
receiving radiation as a component of their care but no
chemotherapy are assigned to a radiation oncology representative. The individuals ultimately responsible for
completing the SCP-TS documents are either physicians or
midlevel providers, but all are members of the Breast
Oncology Program. A nurse (S.C.) and SCP supervising
physician (E.P.) maintain an electronic database of these
patients for monitoring of the time line regarding when each
patient is due to receive the SCP-TS document.

Step 2: Do

Step 3: Study

Step 4: Act
Results of comparative System I versus System II analyses
were shared with Breast Oncology Program colleagues, and
plans were made regarding continuation of System II.
RESULTS
We evaluated the accuracy of 71 SCP-TS documents
generated before launching the MDC-SCP program (System I) and 93 SCP-TS documents generated through
the MDC-SCP program (System II). As shown in Table 1,
accuracy of the entries of the System II SCP-TS documents was never inferior to those of System I documents.
Both presented accurate information in more than 90% of
documents regarding identiﬁcation of treatment team
members. Both systems had notable inaccuracies in
documenting type of surgery performed, but System II had
fewer inaccuracies than System I (33.78% v 51.67%,
respectively; P = .05). System II documented the correct
date of diagnosis more often than System I (90.3% v 73.2%,
respectively; P = .01) and more often correctly listed
all surgeries in patients requiring multiple operative
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• July-August 2018: Multidisciplinary
SCP-TS program (System II)
accuracy confirmed; program to
continue, with plans for enhanced
evaluation of effectiveness with
regard to surveillance and
survivorship metrics

• August-October 2016: Design of a
multidisciplinary team–based SCPTS conference system; transition
from non–breast team–based
approach (System I) to new
multidisiciplinary conference
approach (System II)

Act

Plan

Study

Do

• May-July 2018:
Completion of SCP-TS
reviews for System I versus
System II; analysis of comparative
accuracy for System I versus
System II

FIG 1. Implementation of a Plan-Do-Study-Act (PDSA)
strategy to evaluate and improve the accuracy of
breast cancer survivorship care plan (SCP) treatment summaries (TSs) using a multidisciplinary
team approach. Our goal was improved oversight
and accuracy of SCP-TS through application of a
multidisciplinary conference–based system.

• October 2016-June 2018:
Monthly multidisciplinary
SCP-TS conference program
(System II) underway,
with tracking of documents

procedures (64.9% v 48.3%, respectively; P = .05). Among
patients receiving radiation, the dose was documented
correctly more often in System II SCP-TS documents
compared with System I documents (76.0% v 49.2%,
respectively; P , .01). Both systems functioned poorly in
documenting correct surgery dates in patients requiring
multiple operative procedures (54.5% for System I and
52.6% for System II; P = .62).
DISCUSSION
The CoC previously mandated that at least 25% of eligible
patients receive SCP-TS documents by the end of 2016, at
least 50% by the end of 2017, and at least 75% by the end
of 2018. This mandate has been revised, currently requiring that at least 50% of eligible patients receive SCP-TS
documents by the end of 2018.2 The actual mechanism for
implementing the SCP program was left to the discretion of
individual sites. Ongoing uncertainty persists regarding the
assignment of responsibilities (to physicians v advanced
practice provider; to specialists v nonspecialists) for drafting
and discussing the SCP-TS with the patient.
As reviewed by Nekhlyudov et al,5 tremendous progress
has been made with integrating survivorship needs into
oncology follow-up programs, but signiﬁcant gaps remain in
assessment of program effectiveness. Burke et al6 used
focus groups to demonstrate the need for patient education
regarding the transition between active cancer treatment
and survivorship. Nonetheless, an umbrella meta-analysis
conducted by D’Souza et al7 revealed the paucity of actual
data regarding best practices in survivorship care planning.
Preliminary studies are emerging that evaluate accuracy of
TS documents and effectiveness of SCP activities in

achieving the overarching goal of improved health and wellbeing among survivors of cancer. Tevaarwerk et al8 analyzed the TS component of the University of Wisconsin SCP
program and reported an overall error rate of 25%. Maly
et al9 conducted a prospective randomized controlled trial
(to our knowledge, the ﬁrst ever to assess SCPs) in a
California-based cohort of 212 low-income and predominately Latina patients with breast cancer. Patients
either participated in a nurse-run SCP-TS program or received the usual medical care. The intervention group was
found to have improved enactment of strategies to control
symptoms such as depression and hot ﬂashes. Palmer
et al10 documented high rates of patient satisfaction with
SCP-TS documents.
Others have explored novel mechanisms to support SCP-TS
programs, such as use of lifestyle consultants.11 EMRbased systems to provide automated infrastructure to the
SCP-TS program are potentially attractive,12 but as demonstrated by Donohue et al,13 special training is often
necessary to facilitate efforts of health care providers in
locating and using these systems.
We chose to focus initially on assessing accuracy of the TS
provided to our patients with breast cancer. We aimed to
address anecdotal concerns regarding the accuracy of our
standard clinic-based approach, featuring TSs drafted and
delivered to patients by individual providers. Of note, our
multidisciplinary team opted to include some details in our
templated SCP-TS documents that are not required by the
CoC. For example, we include radiation dose as well as year
and month for documentation of dates, whereas the CoC
makes the documentation of month optional. We conducted a PDSA-type quality improvement review to
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TABLE 1. Evaluation of Accuracies in Documentation Entries Within Survivorship Care Plan Treatment Summaries Generated by a Traditional
Clinic-Based and Nonspecialist Approach (System I) Compared With Those Generated by a Multidisciplinary, Breast Specialist Conference-Based
Approach (System II)
No. of Documents (%)
Documentation Element and Entry

System I (n = 71)

System II (n = 93)

66 (92.96)

92 (98.92)

Incorrect

4 (5.63)

1 (1.08)

Missing

1 (1.41)

0 (0.00)

P*

Members of treatment team
Surgeon

.11

Correct

Medical oncologist

.03

Correct

66 (92.96)

92 (98.92)

Incorrect

1 (1.41)

1 (1.08)

Missing

4 (5.63)

0 (0.00)

Radiation oncologist

.51

Correct

60 (84.51)

77 (82.80)

Incorrect

1 (1.41)

0 (0.00)

Missing

10 (14.08)

16 (17.20)

Correct

69 (97.18)

91 (97.85)

Missing

2 (2.82)

2 (2.15)

Primary care provider

1.00

Histology

.40

Correct

68 (95.77)

92 (98.92)

Incorrect

2 (2.82)

1 (1.08)

Missing

1 (1.41)

0 (0.00)

Date of diagnosis

.01

Correct

52 (73.24)

84 (90.32)

Incorrect

18 (25.35)

9 (9.68)

Missing

1 (1.41)

0 (0.00)

Staging information† (tumor size and nodal status)
Correct

.131
66 (93)

85 (91.4)

Incorrect

3 (4.2)

8 (8.6)

Missing

2 (2.8)

0 (0.00)

Among patients receiving neoadjuvant chemotherapy,
staging information†

.863

Correct

6 (85.7)

14 (87.5)

Incorrect

1 (14.3)

2 (12.5)

Among patients not receiving neoadjuvant chemotherapy,
staging information†
Correct

.139
60 (93.8)

71 (92.2)

Incorrect

2 (3.1)

6 (7.8)

Missing

2 (3.1)

0 (0.00)

69 (97.18)

92 (98.92)

1 (1.41)

0 (0.00)

1 (1.41)

1 (1.08)

Estrogen receptor status

.72

Correct
Incorrect
Missing

(continued on following page)
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TABLE 1. Evaluation of Accuracies in Documentation Entries Within Survivorship Care Plan Treatment Summaries Generated by a Traditional
Clinic-Based and Nonspecialist Approach (System I) Compared With Those Generated by a Multidisciplinary, Breast Specialist Conference-Based
Approach (System II) (continued)
No. of Documents (%)
Documentation Element and Entry

System I (n = 71)

System II (n = 93)

Progesterone receptor status
Correct

69 (97.18)

91 (97.85)

Incorrect

1 (1.41)

1 (1.08)

Missing

1 (1.41)

1 (1.08)

68 (95.77)

90 (96.77)

Incorrect

0 (0.00)

0 (0.00)

Missing

3 (4.23)

3 (3.23)

HER2/neu status

1.00

Correct

Among patients undergoing single surgical procedure, the
date of surgery was documented accurately
Correct

.16
58 (96.67)

72 (97.30)

Incorrect

0 (0.00)

2 (2.70)

Missing

2 (3.33)

0 (0.00)

Among patients undergoing one single surgical procedure,
type of surgery was documented accurately

.05

Correct

29 (48.33)

48 (64.86)

Incorrect

31 (51.67)

25 (33.78)

Missing

0 (0.00)

1 (1.35)

Among patients undergoing multiple surgical procedures,
all surgery dates were documented accurately

.62

Correct

6 (54.5)

10 (52.6)

Incorrect

3 (27.3)

3 (15.8)

Missing

2 (18.2)

6 (31.6)

Among patients undergoing multiple surgical procedures,
type of all procedures was documented accurately

.27

Correct

5 (45.45)

9 (47.37)

Incorrect

5 (45.45)

4 (21.05)

Missing

1 (9.09)

6 (31.58)

Among patients receiving chemotherapy, adjuvant v
neoadjuvant sequence was documented
accurately
Yes

NA

16 (100)

51 (100)

Among patients receiving chemotherapy, regimen was
documented accurately
Yes

NA
16 (100)

51 (100)

Among patients receiving endocrine therapy, medication(s)
was documented accurately

.85

No

2 (3.45)

1 (1.25)

Yes

54 (93.10)

76 (95.00)

2 (3.45)

3 (3.75)

Missing

P*
1.00

(continued on following page)
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TABLE 1. Evaluation of Accuracies in Documentation Entries Within Survivorship Care Plan Treatment Summaries Generated by a Traditional
Clinic-Based and Nonspecialist Approach (System I) Compared With Those Generated by a Multidisciplinary, Breast Specialist Conference-Based
Approach (System II) (continued)
No. of Documents (%)
Documentation Element and Entry

System I (n = 71)

P*

System II (n = 93)

, .01

Among patients receiving radiation, dose was documented
accurately
No

10 (16.95)

11 (14.67)

Yes

29 (49.15)

57 (76.00)

Missing

20 (33.90)

7 (9.33)

Among patients receiving radiation, ﬁelds and tangents
were documented accurately
No

.86
4 (6.78)

7 (9.33)

Yes

38 (64.41)

49 (65.33)

Missing

17 (28.81)

19 (25.33)

Abbreviations: HER2/neu, human epidermal growth factor receptor 2; NA, not applicable.
*P values were obtained using the Fisher’s exact test. The missing category was included in the statistical testing.
†Staging information included tumor size and nodal status.

evaluate an alternative SCP-TS program. The alternative
program featured a multidisciplinary conference–based
review of SCP-TS documents prepared in advance by
speciﬁc members of the breast program team on the basis
of the treatment history of the individual patient. The
multidisciplinary breast program–based discussion of the
TSs improved content accuracy and is being continued.
Our hope is that multidisciplinary review will minimize the

human error associated with individual, nonreviewed data
entry. Therefore, we anticipate expansion to other cancer
disease sites. For our patients with breast cancer, a followup PDSA will evaluate documentation of surgical procedures more closely, and we will evaluate additional
metrics, such as conﬁrming that patients resume overall
health maintenance plans and have addressed control of
cancer treatment toxicities.
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